|Articles|October 2, 2021
Using ML, AI and RWD to Infer HCP Specialties
Author(s)IPM.ai
Pharmaceutical sales operations teams often rely on outdated or inaccurate data when prioritizing HCP targets, limiting promotional effectiveness. By applying artificial intelligence and machine learning to real world data, pharmaceutical companies can more effectively target physicians hiding in plain sight and PCPs behaving like specialists.
Related Content
Trending on PharmExec
1
The Agentic AI Revolution in Biopharma
2
How Cortisol-Targeted Approaches Might be Paired with GLP-1 Medications
3
Novartis Investors Share Concerns Over M&A Strategy: Report
4
Artisan Partners’ Director Calls for Novartis Board Shake-Up
5